Albatroz Therapeutics

In the News

11/07/2023

Albatroz Co-Founder and CEO, Dr. Fredric Bard is spotlighted by A*STAR – Agency for Science, Technology and Research for his insights as a scientist-entrepreneur

10/18/2023

Albatroz Named One of Six Companies Leading Singapore’s Biotech Scene

10/10/2023

Albatroz Featured in the Novo Nordisk Singapore Partnering Day 2023

09/12/2023

Albatroz Co-Founder Presents at the ‘Biomedical Innovation in Asia’ Workshop

07/05/2023

In Vivo Spotlights Albatroz’s Science and the Leadership of Guy Heathers

06/07/2023

BioWorld Recognizes Albatroz Science, Leadership, and Progress Toward Blocking a Highly Specific Target to Block Growth and Spread of Solid Tumors and Cartilage Degradation

04/06/2023

Albatroz Therapeutics Featured in A *STAR Research Highlights

11/11/2020

Albatroz Therapeutics Selected as Finalist in the 2020 Brace Award Venture Competition